Cardiac Surgery Flashcards

1
Q

Unstable angina definition

A

rupture of atherosclerotic plaques of coronary arteries causing increased ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

STEMI & NSTEMI definition

A

disruption of atherosclerotic plaque of coronary arteries causing platelet aggregation and clot formation, causing high grade stenosis or occlusion of coronary
artery with or without associated emboli entering microcirculation downstream, resulting in ischemia and infarction of myocardium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Definitions of typical and atypical angina

A

typical angina that is severe and prolonged (>20 minutes)

typical angina satisfies all 3 criteria:
1) retro sternal pressing pain radiating to shoulder / jaw / arm
pain sometimes described as pressure, tightness, heaviness
pain usually diffuse and not localized
angina usually last minutes, rarely seconds or days

2) provoked with exertion or emotional stress

3) relieved with rest or nitroglycerin
atypical angina only satisfies 1-2 of the 3 criteria above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does it mean if angina lasts < or > 20 minutes

A

angina lasting <20 minutes = myocardial ischemia angina

> 20 minutes = acute coronary syndrome (i.e. unstable angina or myocardial infarction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CCS classification of angina

A

class 1 = no limitation of ordinary activity; angina with strenuous, rapid or prolonged exertion

class 2 = slight limitation of ordinary activity; angina with ordinary activity (walking stairs, walking uphill) after meals, in cold, in wind or under emotional stress

class 3 = marked limitation of ordinary activity; angina on walking or climbing short distances under normal condition and at normal pace

class 4 = inability to carry on ordinary activity; angina at rest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 presentations of unstable angina

A

crescendo pattern with increase in frequency, duration or intensity

angina at rest without provocation

new onset of severe angina (CCS class 3) without previous angina

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ACS investigations

A

ECG at presentation, often repeated if patient still has symptoms

blood laboratory tests: troponin and CK-MB (usually repeated at 6 and 9 hours after initial assessment if it is negative at 0 hour)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ECG ACS “rules”

A

on ECG, infarct follows 2 rules

1) territorial: where ST elevation in territorial leads (inferior = II, III, aVF; anterior = V1, V2, V3, V4; lateral = V5, V6, I, aVL)

inferior = II, III, aVF = right coronary artery (RCA)

lateral = I, aVL, V5, V6 = I, aVL by left circumflex (CCX) artery; V5, V6 by branch of left anterior descending (LAD) artery

anterior = V1, V2, V3, V4 = left anterior descending (LAD) artery

2) reciprocal changes: ST depression in leads opposite to territorial leads with ST elevation

reciprocal leads includes 1) lateral leads to inferior leads; 2) anterior leads to posterior leads; 3) sometimes anterior to inferior leads

by this rule, ST depression in anterior leads requires a 15 leads ECG (posterior leads V7, V8, V9) to rule out STEMI in posterior leads

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ischemia findings on ECG

A

on ECG, ischemia manifested commonly as ST depression or T wave inversion, but can also have biphasic T waves

ST depression or T wave inversion due to ischemia usually do not follow territorial leads

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cardiac enzyme markers and their meanings

A

cardiac enzyme markers include myoglobin, CK-MB, troponin I, troponin T

troponin I is most specific and sensitive, which will start to elevate 3-12 hours post infarct, peak at 10-24 hours post infarct and return to baseline in 3-10 days

delayed (i.e. after 6-9 hours) negative troponin rules out infarction

early (i.e. <6 hours) negative troponin does not rule out anything

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Management for STEMI

A

Stabilize. Then patients with STEMI require all of the following

A) supplemental oxygen to achieve O2 saturation >92%

B) anti-platelets, most commonly Aspirin and (Clopidogrel or Ticagrelor)
cardiologist may also add glycoprotein IIb/IIIa inhibitor (GP IIb/IIIa)

C) anti-thrombin, most commonly Heparin (unfractionated or low molecular weight) or Fondaparinux

D) vessels opened, either percutaneous coronary intervention (PCI) or fibrinolytic agent (tPA)
PCI (balloon angioplasty to open occluded coronary vessel) if within 90 minutes of catheter lab
multiple blocks or occlusion not amenable to PCI may be candidate to coronary artery bypass graft (CABG) surgery
tPA if >90 minutes of catheter lab given no contraindication to anti-fibrinolytic

E) symptomatic treatment
morphine and nitroglycerin to relieve chest pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Who should not receive nitro

A

Patients taking sildenafil

nitroglycerin should not be given to patients with suspected right ventricular infarct, because it decreased preload and causes cardiovascular collapse (hypotensive shock)
all patients with inferior infarct should have right leads (V4R) to rule out right ventricular infarct, which would have ST elevation in V4R, before giving nitroglycerin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Management of unstable angina or NSTEMI

A

some elements may change according to risk

A) supplemental oxygen to achieve O2 saturation >92%

B) anti-platelets, most commonly Aspirin and (Clopidogrel or Ticagrelor)
cardiologist may also add glycoprotein IIb/IIIa inhibitor (GP IIb/IIIa)

C) anti-thrombin, most commonly Heparin (unfractionated or low molecular weight) or Fondaparinux

D) vessels opened, either percutaneous coronary intervention (PCI) or fibrinolytic agent (tPA)
decision depend on risk stratification

E) symptomatic treatment
morphine and nitroglycerin to relieve chest pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of unstable angina or NSTEMI risk stratification

A

management based on risk stratification by TIMI score

TIMI score based on 7 criteria, each worth 1 point each

1) age >65
2) >3 cardiac risk factors (diabetes, smoking, dyslipidemia, hypertension, family history of premature cardiovascular disease)
3) known coronary artery disease with stenosis >50%
4) aspirin use within last 7 days
5) severe angina with >2 episodes within 24 hours
6) ECG ST changes (elevation or depression >0.5mm)
7) elevated cardiac markers

TIMI score predicts risk of death, MI or ischemia within next 14 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Non-ST elevated ACS low risk group classification and management

A

ECG: normal

TIMI score 0-2

Management:
(ASA, statin, nitro for all)
B-blocker
Early discharge with follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Non-ST elevated ACS intermediate risk group classification and management

A

ECG: normal or T wave inversion

TIMI score 3-4

Other: Previous CABG or PCI

Management: 
(ASA, statin, nitro for all) 
Heparin
Clopidigrel 
Observation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Non-ST elevated ACS high risk group classification and management

A

ECG: ST shift or deep T wave inversion

TIMI score 5-7

Other:
Positive or negative cardiac markers
Refractory ischemia, heart failure or hypotension

Management:
(ASA, statin, nitro for all)
Heparin
GP IIb/IIIa inhibitor or bivalirudin with Clopidigrel
B-blocker
Early catheterization (for assessment and revascularization)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Aortic dissection pathophysiology

A

tear or disruption of intimal layer of aorta where blood flow tears and continues to dissect intimal layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Aortic dissection complications

A

rupture of aorta, causing exsanguination

clot in false lumen, compromising downstream blood vessels branching from the aorta, resulting in ischemia of tissue such as brain, heart, kidney, GI tract, limbs

bleeding into pericardium resulting in cardiac tamponade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Aortic dissection history/risk factors

A

1 risk factor = hypertension

structural risk factors: connective tissue disease (Marfan’s, Ehler-Danlos syndrome), bicuspid aortic valve, aortic co-arctation, valve replacement, coronary artery bypass graft surgery

other risk factors including smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Aortic dissection clinical presentation

A

in general, patient with aortic chest pains look unwell and are hemodynamically unstable (tachycardia, hypertension or hypotension, syncope)

abrupt onset

typically, sharp tearing chest pain 10/10 radiating to back between scapula, maximum at onset

pain can be described as searing, throbbing and may radiate to jaw or abdomen

associated symptoms mainly due to ischemia of brain, heart, GI system and limbs

brain ischemia results in stroke (loss of consciousness, aphasia, limb weakness, paralysis)

heart ischemia results in angina, syncope, myocardial infarction, cardiac tamponade

GI ischemia results in abdominal pain

limb ischemia results in limb pain, cold & pulseless leg

rupture into body cavity ->
hemothorax causing hemoptysis, dyspnea hemoperitoneum causing hypotensive shock, peritonitis
pericardium causing cardiac tamponade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Aortic dissection mortality

A

40% immediate mortality

1% mortality risk per hour for next 48 hours

5-20% mortality even with surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Aortic dissection physical exam

A

vitals: hypertensive (or hypotensive if cardiac tamponade), tachypnea, tachycardia

cardiovascular exam: discrepancy in blood pressure (>20-30mmHg) between 2 arms, weak one sided pulse, aortic regurgitation murmur (decrescendo diastolic murmur)

neurological: focal neurological deficit

abdominal exam: pain, pulsatile abdominal mass

peripheral vascular exam: acute limb ischemia (cold, dusky, pulseless leg)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Aortic dissection investigations

A

chest X-ray: wide mediastinum loss of normal aortic contour, hemothorax

12% patients with aortic dissection have normal chest X-ray, so normal chest X-ray does not rule out aortic dissection

bed side trans-thoracic (TT) or trans-esophageal (TE) ultrasound: pericardial effusion and tamponade on TT or TE, dissection flap on TE

ECG: left ventricular hypertrophy, ischemic changes, pericarditis, heart block

chest CT angiography: gold standard to diagnose aortic dissection, where it shows aortic branch involvement and pericardial effusion
chest CT angiography requires patient to be stable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Aortic dissection diagnosis
diagnosis based on chest CT angiography
26
Aortic dissection management
1) stabilize patient: ABCs IV medication to lower blood pressure 2) specific treatment Stanford type A dissection = involvement of ascending aorta with higher mortality risk (compromises vessels to head and coronaries, with pericardial sac), treated with surgery with cardiopulmonary bypass surgery = open aorta at proximal extent of dissection and then sew graft to intimal flap and adventitia circumferentially surgical complication: renal failure, mesenteric ischemia, stroke, paraplegia, persistent leg ischemia, death 60% mortality rate peri-operative and post-operative Stanford type B dissection = no involvement of ascending aorta, treated with IV beta-blocker (Labetalol) to lower blood pressure and may involve surgical consultation intervention only if complications (rupture or significant occlusion of true lumen causing ischemia) , where treatment can be surgical repair or endovascular catheterization
27
Pulmonary embolism pathophysiology
PE often originate from deep leg veins from proximal to deep: external iliac -> common femoral -> deep femoral, superficial femoral -> popliteal -> anterior & posterior tibial, peroneal from leg deep vein thrombosis, a clot broke off as embolus, which then entered circulation and became lodged in pulmonary circulation (artery branches), which can have 2 potentially deadly consequences 1) dead space (ventilation but no perfusion) and hypoxemia 2) increased pulmonary vasculature resistance, causing right ventricular strain and possible failure, leading to cardiovascular collapse
28
Virchow's triad risk factors
Stasis: immobilization such as from bed-ridden, post-surgery, long leg cast, long flights / train rides hypercoagulable state: inherited thrombotic disorder (protein C/S deficiency, Factor V Leiden), malignancy, inflammatory disorders (systemic lupus erythematosus, inflammatory bowel disease), pregnancy & post-partum, hormone replacement / oral contraceptive pill endothelial injury: central venous catheter, surgery
29
PE clinical presentation
abrupt or gradual onset pain on one side of chest, typically do not radiate, worse with inspiration associated symptoms include dyspnea, syncope, cough, hemoptysis and palpitation severe PE cause cardiovascular collapse including syncope and cardiac arrest associated with deep vein thrombosis (leg swelling, pain)
30
PE physical exam
vital signs: fever, hypotension, tachycardia, tachypnea, low oxygen saturation (hypoxemia) general appearance: respiratory distress cardiovascular exam: increased JVP, peripheral edema, S3 or S4 respiratory exam: decreased breath sounds, rales leg: signs of DVT such as swelling, erythema, warmth, palpable cord and tenderness
31
PE investigations
chest X-ray: band atelectasis, decreased lung volume on affected side, pulmonary infarct / hemorrhage, edema, Hampton’s hump (wedge shape against pleura) most PE patients will have normal chest X-ray, so chest X-ray mainly to rule out other causes including congestive heart failure, pneumonia, pneumothorax, pleural effusion ECG: tachycardia in 40% PE cases, right ventricular strain (inverted T wave and ST depression in V1-V4) in 30% cases, right bundle branch block (RBBB) in 20% cases, S1Q3T3 (S wave in lead I, Q wave in lead III, inverted T wave in lead III) in 20% cases, atrial fibrillation normal ECG does not rule out PE, but can rule out STEMI and pericarditis arterial blood gas: hypoxemia, hypocapnia, high Aa gradient, respiratory alkalosis laboratory test: D-dimer positive compression ultrasound (CUS) of leg: deep vein thrombosis bed side ultrasound of heart: right ventricle dilatation CT pulmonary angiography (CTPA) or ventilation perfusion scan (VQ scan) as confirmatory tests: can visualize embolism or decreased perfusion
32
PE diagnosis
patients first stratified into a) very low risk; b) low risk; c) high risk, which dictates confirmatory tests to rule in or out PE ``` 1) PERC rule to stratify patient into very low risk patients ruled out by PERC if patient meets NONE of the following criteria age >50 tachycardia HR>100 oxygen saturation <94% prior DVT or PE recent trauma or surgery hemoptysis exogenous estrogen use symptoms and signs of DVT ``` patient PERC negative with low clinical suspicion of PE requires no further work-up for PE (i.e. only chest X-ray, ECG and blood work, no D-dimer, no CTPA, no VQ scan) patient PERC positive need to be stratified into low or high risk based on Well’s score 2) Well’s score to stratify patient into low or high risk pretest probability of PE based on Well’s score divide into low risk (<4 points) or high risk (>4 points) investigations based on Well’s score in low risk patients, PE can be ruled out with a negative D-dimer in low risk patients with positive D-dimer, CTPA is needed to rule out PE in high risk patients, PE is ruled in or out with CTPA
33
What is the Modified Well's Score for PE
Active cancer +1 Hemoptysis +1 Recent immobilization or surgery +1.5 Tachycardia (>100 beats/min) +1.5 Past history of DVT or PE +1.5 Signs or symptoms of DVT based on clinical judgment +3 No alternative diagnosis as or more likely than PE +3
34
PE management
1) stabilize and address ABC (supplemental oxygen if hypoxemia, IV fluids if hypotension) 2) break clots in PE for massive PE causing cardiovascular compromise (hypotension, tachyarrhythmia, syncope, cardiac arrest), fibrinolytics for hemodynamically stable PE, anticoagulants commonly low molecular weight heparin (LMWH) for short term while starting warfarin for long term
35
PE disposition
patients risk stratified by simplified PE Severity Index (PESI) for determining disposition simplified PESI includes following variables, each worth 1 point: age >80 years history of cancer history of heart failure or chronic lung disease tachycardia >110 beats / min hypotension where systolic blood pressure <100mmHg hypoxia where oxygen saturation <90% low risk = 0 point; high risk > 1 point patients with low risk have low risk (1%) for 30 day mortality, thus can be discharged home to be followed up as outpatient patients with high risk have higher risk (10%) for 30 day mortality, thus need to be admitted as inpatient
36
Definition of systolic dysfunction
heart unable to contract or pump blood efficiently into circulation caused by impaired contractility or increased after load reduced ejection fraction
37
Definition of diastolic dysfunction
heart unable to fill properly between each beat caused by decreased compliance preserved ejection fraction
38
Clinical presentation of heart failure
``` F = Fatigue A = Activities limited, exercise intolerance C = Chest congestion E = Edema including ascites, peripheral edema S = Shortness of breath including dyspnea, orthopnea, paroxysmal nocturnal dyspnea (PND) ```
39
NYHA classification of heart failure
heart failure symptoms graded on New York Heart Association (NYHA) classification, which dictate prognosis and management Class I: no symptoms; able to perform ordinary activities without limitations Class II: mild dyspnea and fatigue with moderate exertion; occasional swelling of ankles and feet; somewhat limited in exercise and strenuous activities; no symptoms at rest Class III: symptoms (dyspnea) with minimal exertion; noticeable limitation inability to exercise and participate in mildly strenuous activities; comfortable only at rest Class IV: symptoms (dyspnea) at rest; unable to do any physical activity without discomfort
40
ACC / AHA staging of heart failure
ACC / AHA staging of heart failure based on structural changes and symptoms Stage A: patient at high risk of heart failure, but has no structural heart disease currently Stage B: structural heart disease (myocardial infarction, left ventricular hypertrophy, low ejection fraction, valvular disease) but no symptoms Stage C: current or prior symptoms of heart failure; structural heart disease with symptoms Stage D: refractory heart failure; marked symptoms despite maximal medication and hospitalization
41
Types of valve prosthesis and their advantages, disadvantages and contraindication
valve prosthesis can be mechanical or bioprosthetic general rule: mechanical prosthesis for age <70 for durability; bio-prosthetic valve for age >70 for no anti-coagulation 1) Mechanical Valve advantage: good durability disadvantage: increased risk of thromboembolism requiring long-term anti-coagulation, not indicated in small aortic root sizes anti-coagulation with Warfarin target INR 2-3 for aortic valve; 2.5-3.5 for mitral valve, 1-2% hemorrhage risk per year contraindication: pregnancy or possibility of pregnancy (due to risk of anti-coagulation), bleeding risk 2) Bio-prosthetic Valve advantage: decreased risk of thromboembolism where long term anti-coagulation is not indicated, good flow in small aortic root sizes disadvantage: limited long term durability contraindication: dialysis
42
Valve prosthesis interventions and their contraindications, advantages and disadvantages
intervention to replace valve can be surgery or percutaneous (i.e. via catheterization) 1) Surgery contraindication: unsuitable surgical candidate due to comorbidity advantage: standard of care, able to operate on patients where catheterization is contraindicated (see below) disadvantage: invasive, requires cardiopulmonary bypass 2) Percutaneous balloon valvuloplasty for stenosis, valve replacement for regurgitation advantage: contraindication: severe coronary artery disease / recent myocardial infarction, cannot take anti-coagulants
43
Aortic stenosis pathophysiology
cause: calcification of aortic valve, rheumatic heart disease, congenital aortic stenosis outflow obstruction -> increased after load -> left ventricular hypertrophy -> eventual systolic dysfunction -> congestive heart failure
44
Aortic stenosis clinical presentation
symptomatic at late stage: SAD = syncope, angina, dyspnea (exertional) in order of angina (5 years life expectancy) -> syncope (3 years life expectancy) -> dyspnea (2 years life expectancy) physical exam: delayed and decreased volume carotid pulse, systolic ejection murmur at right upper sternal border
45
Aortic stenosis investigation
echocardiogram: valve area, pressure gradient, left ventricular hypertrophy (LVH), left ventricular ejection fraction (LVEF) ``` normal aortic valve area = 3-4cm2 mild stenosis = 1.5-3cm2 moderate stenosis = 1-1.5cm2 severe stenosis <1cm2 critical stenosis <0.5cm2 ```
46
Aortic stenosis relative contraindications
avoid ACEI and nitrate
47
Aortic stenosis intervention
procedure = aortic valve replacement, surgical or percutaneous catheterization indication for intervention: 1. symptomatic 2. aortic valve area <1cm2 (exception = normal exercise test with no decrease in blood pressure and normal echocardiogram without left ventricular hypertrophy) 3. echocardiogram: LVH, low LVEF, aortic valve gradient >50mmHg
48
Aortic regurgitation pathophysiology
cause: aortic root dilatation, bicuspid aortic valve, infective endocarditis aortic regurgitation -> volume overload in left ventricle -> transfer of volume into left atrium and lung -> congestive heart failure aortic regurgitation -> regurgitation in cause low diastolic pressure (due to regurgitation) and also increased systolic pressure (due to increased stroke volume)
49
Aortic regurgitation clinical presentation
acute: pulmonary edema from lung congestion chronic: exertional dyspnea, angina, fatigue physical exam: wide pulse pressure, bounding water hammer pulse, early diastolic decrecendo murmur (best at end expiration with leaning forward) at lower left sternal border
50
Aortic regurgitation investigation
echocardiogram: quanitfy aortic regurgitation, visualization of leaflet or aortic root anomalies
51
Aortic regurgitation medical management
avoid exertion treatment of CHF according to CHF guidelines (ACEI, beta-blocker, Furosemide)
52
Aortic regurgitation intervention
procedure = aortic valve replacement, surgical or percutaneous catheterization if aortic root dilatation, then aortic root replacement with valved conduit (Bentall procedure) ``` indication for intervention 1. symptomatic especially if NYHA class 3-4 CHF ``` 2. echocardiogram: low left ventricular ejection fraction (LVEF) <50% or dilated left ventricle
53
Mitral stenosis pathophysiology
cause: rheumatic heart disease mitral stenosis -> increased left atrial pressure -> pulmonary congestion -> pulmonary hypertension -> right heart failure mitral stenosis -> increased left atrial pressure -> atrial enlargement -> atrial fibrillation -> increased risk of thromboembolis
54
Mitral stenosis clinical presentation
pulmonary congestion: dyspnea, orthopnea, paroxysmal nocturnal dyspnea other: hemoptysis, hoarseness from impingement of recurrent laryngeal nerve complication: atrial fibrillation, thromboembolism physical exam: opening snap then decrescendo murmur during diastole at apex
55
Mitral stenosis investigation
echocardiogram: mitral valve area, pulmonary hypertension severe mitral stenosis if mitral valve area <1.2cm2
56
Mitral stenosis medical management
avoid exertion treat atrial fibrillation (anti-coagulation, rate or rhythm control) and CHF according to CHF guidelines (ACEI, beta-blocker, Furosemide) beta-blocker, digitalis
57
Mitral stenosis intervention
procedure = percutaneous balloon valvuloplasty, surgical open mitral commissurotomy, mitral valve replacement (surgical or percutaneous) ``` indication for intervention 1. symptomatic NYHA class 3-4 CHF ``` 2. echocardiogram: severe mitral stenosis <1.5cm2 or pulmonary hypertension 3. complication: atrial fibrillation or recurrent thromboembolism
58
Mitral regurgitation pathophysiology
cause: rheumatic heart disease, ruptured cordae, papillary dysfunction (post myocardial infarction), mitral prolapse, LV dilatation, infective endocarditis mitral regurgitation -> increased left atrial enlargement -> pulmonary congestion -> pulmonary hypertension mitral regurgitation -> decreased cardiac output -> forward heart failure
59
Mitral regurgitation clinical presentation
pulmonary congestion: dyspnea, orthopnea, paroxysmal nocturnal dyspnea low cardiac output: fatigue physical exam: holosystolic systolic murmur radiating to axilla
60
Mitral regurgitation investigation
echocardiogram: severity of mitral regurgitation, left ventricular function, visualization of mitral leaflet, papillary muscle, cord abnormalities
61
Mitral regurgitation medical management
diuretics, ACEI
62
Mitral regurgitation intervention
procedure 1st line = surgical repair of mitral valve (annuloplasty ring, leaflet repair, chordae transfer / replacement) 2nd line = valve replacement (surgical or percutaneous) if surgical repair not possible indication for intervention 1. if mitral valve surgical repair possible and patient is a good surgical candidate, then as early as possible 2. symptomatic especially if NYHA class 3-4 CHF 3. echocardiogram: low LVEF <60%, left ventricular dilatation, pulmonary hypertension 4. complication: atrial fibrillation
63
Types of cyanotic congenital heart disease
5 T’s tetralogy of Fallot Transposition of Great Vessel Truncus artheriosus Total anomalous pulmonary venous drainage Tricuspid atresia other: hypo plastic left heart syndrome, Ebstein’s anomaly
64
What is cyanotic congenital heart disease
right to left shunt resulting in de-oxygenated blood in systemic circulation
65
Causes of acyanotic congenital heart disease
left to right shunt: atrial septal defect, ventricular septal defect, patent ductus arteriosus Obstructive: aortic coarctation, aortic stenosis, pulmonic stenosis
66
What is Eisenmenger's syndrome
left to right shunt cause left ventricular dysfunction -> congestive heart failure, right ventricular hypertrophy, pulmonary hypertension -> reversal to right to left shunt
67
Congenital heart disease diagnosis
almost all congenital heart disease diagnosed based on echocardiogram
68
Atrial septal defect epidemiology
~10% congenital heart disease
69
Atrial septal defect types and pathophysiology
3 types: osmium primum, osmium scandium (most common type 50-70% cases), sinus venosus continuous left to right shunt through atrial septal defect
70
Atrial septal defect clinical presentation
usually asymptomatic in childhood physical exam: widely split and fixed S2, systolic ejection murmur
71
Atrial septal defect complications
congestive heart failure, pulmonary hypertension
72
Atrial septal defect management
surgery: suture closure of atrial septal defect (may be done by percutaneous catheter)
73
VSD epidemiology
30-50% congenital heart disease
74
VSD clinical presentation
mild = asymptomatic mild to severe = exercise intolerance, recurrent asthma / upper respiratory tract infection episodes physical exam: holosystolic murmur at left lower sternal border with thrill, mid-diastolic rumble at apex
75
VSD complications
congestive heart failure, pulmonary hypertension
76
VSD management
surgery: closure of ventricular septal defect with surgical patch (may be done by percutaneous catheter)
77
PDA epidemiology
5-10% congenital heart disease
78
PDA clinical presentation
may be asymptomatic, but have apneic / bradycardia spell physical exam: tachycardia, bounding pulses, hyperactive precordium, continuous machinery murmur best heard at left intra-clavicular area radiating to back
79
PDA management
Indomethacin (PGE2 antagonist) for closure in premature infant surgery: closure of PDA by surgical ligation (or spring to clot and close PDA by percutaneous catheterization)
80
Coarctation of the aorta pathophysiology
narrowing of aorta, most commonly at level of ductus arteriosus
81
Coarctation of the aorta clinical presentation
often asymptomatic physical exam: low ankle brachial index (ABI), high blood pressure at upper extremity & low blood pressure at lower extremity, weak / absent pulses in lower extremity, radial-femoral delay, systolic murmur with late peak at apex / left axilla / left back
82
Coarctation of the aorta complication
hypertension
83
Coarctation of the aorta management
if pre-ductus arteriosus, then prostaglandin to keep ductus arterioles patent surgery: catheterization balloon dilatation +/- stent of aorta at site of coarctation
84
Pulmonary stenosis pathophysiology
stenosis causing obstruction of blood flow to pulmonary artery and lung 90% stenosis at valve, but obstruction can be at sub-valvular or supra-valvular
85
Pulmonary stenosis clinical presentation
spectrum from asymptomatic to congestive heart failure physical exam: wide split S2, systolic ejection murmur at left upper sternal border, pulmonary ejection click
86
Pulmonary stenosis management
surgery: surgical repair at site of obstruction
87
Tetrology of Fallot pathophysiology
1) ventricular septal defect 2) right ventricle outflow tract obstruction (pulmonary stenosis) 3) over-riding aorta 4) right ventricular hypertrophy
88
Tetrology of Fallot clinical presentation
cyanosis, hypoxic tet spells in extertional states, paroxysmal rapid & deep breathing physical exam: loud single S2 due to pulmonary stenosis, systolic ejection murmur at left upper sternal border
89
Tetrology of Fallot management
medical management: supplemental oxygen, knee-chest position, fluid bolus, morphine sulfate, beta-blocker surgery: repair of ventricular septal defect, widening of pulmonary valve
90
Tranposition of Great Arteries epidemiology
5% of congenital heart disease
91
Tranposition of Great Arteries pathophysiology
systemic: body -> right atrial -> right ventricle -> aorta -> body; pulmonary: lungs -> left atrium -> left ventricle -> pulmonary artery -> lungs
92
Tranposition of Great Arteries clinical presentation
progressive cyanosis unresponsive to supplemental oxygen as ductus arteriosus closes
93
Tranposition of Great Arteries treatment
prostaglandin to keep ductus arterioles open surgery: surgical repair with connection of aorta to left ventricle and pulmonary artery to right ventricle
94
Total Anomalous Pulmonary Venous Connection epidemiology
2% of congenital heart disease
95
Total Anomalous Pulmonary Venous Connection pathophysiology
pulmonary veins draining into right atrium instead of left atrium, usually requiring atrial septal defect shunt to stay alive
96
Total Anomalous Pulmonary Venous Connection management
surgery: re-routing pulmonary vein into left atrium
97
Truncus arteriosus pathophysiology
single great vessel arising from heart connecting left and right ventricle to aorta, pulmonary and coronary arteries the trunks overlie a ventricular septal defect
98
Truncus arteriosus management
surgery: closure of ventricular septal defect to include trunks on left ventricle + reconnecting pulmonary artery from trunks to right ventricle
99
Ebstein anomaly pathophysiology
malformed tricuspid valve displaced into right ventricle, causing right ventricular dysfunction, tricuspid stenosis or tricuspid regurgitation associated with patent foramen oval to allow right to left shunting
100
Ebstein anomaly management
surgery: tricuspid valve repair or valve replacement + atrial septal defect closure
101
Hypoplastic left heart syndrome epidemiology
1% of congenital heart disease
102
Hypoplastic left heart syndrome pathophysiology
hypoplasia of left ventricle, mitral and / or aortic valve, small ascending aorta circulation dependent on ductus potency for systemic circulation
103
Hypoplastic left heart syndrome management
medical: intubation, correction of metabolic acidosis, prostaglandin to keep ductus arterioles open surgery: Norwood procedure (connect aorta to right ventricle with connection of pulmonary artery to aorta, such that right ventricle pump blood into both systemic and pulmonary circulation), then heart transplant in adulthood
104
Aortic dissection epidemiology
incidence of 5 in 1 million 3 males to 1 female ratio peak incidence age 50-65 years old
105
Aorta segments
aorta have 5 segments from proximal to distal 1) aortic root from aortic valve to sinotubular junction, giving branch to coronary arteries 2) ascending aorta from sinotubular junction to brachiocephalic artery, no branches 3) aortic arch from brachiocephalic artery to left subclavian artery, giving branch to brachiocephalic artery, left common carotid artery and left subclavian artery 4) descending thoracic aorta from left subclavian artery to diaphragm, giving branch to intercostal arteries 5) abdominal aorta from diaphragm to bifurcation to common iliac artery, giving branch to celiac trunk, superior mesenteric artery, renal arteries, inferior mesenteric arteries and lumbar arteries
106
Stanford and Debakey classifications for aortic dissection
Stanford Classification include type A and B type A: involvement of ascending aorta type B: no involvement of ascending aorta DeBakey classification include 1, 2, 3A, 3B 1 = involvement of ascending and descending aorta 2 = involvement of ascending aorta only 3 = involvement of descending aorta only, where 3A = involvement of thoracic aorta; 3B = involvement of thoracic and abdominal aorta Stanford A = DeBakey 1 and 2 Stanford B = DeBakey 3
107
Major risk factors for coronary artery disease
history of cardiovascular disease 5 big risk factors: 1. dyslipidemia (high LDL, low HDL) 2. smoking 3. diabetes 4. hypertension 5. family history of premature cardiovascular disease Other risk factors: metabolic syndrome, defined as central obesity based on waist circumference (>94cm for men; >80cm for women) plus >2 of following: hypertriglyceridemia (>1.7) low HDL cholesterol (<1 for men, <1.3 for women) hypertension (>130/85 or treatment for hypertension) high fasting glucose (>5.6 mmol/L) or diabetes weight and BMI (normal = 18-25; overweight = 26-29; obese = >30) inflammatory diseases: lupus, rheumatoid arthritis, psoriasis, elevated hs-CRP ethnicity especially south Asian
108
Framingham risk score
Framingham risk score used to calculate future risk of cardiovascular disease for patients with NO history of cardiovascular disease Framingham risk score based on 7 variables: age, gender, total cholesterol, HDL cholesterol, blood pressure, diabetes, smoking history
109
Benefits of revascularization therapy
revascularization improves symptoms & quality of life and reduce risk of MI & premature death
110
Types of revascularization therapy
2 types of revascularization therapy 1) percutaneous coronary intervention (PCI) catheter dilating stenosed coronary artery with balloon and then placing stent PCI require 1 year of Aspirin plus Clopidogrel post PCI 2) coronary artery bypass graft (CABG) surgical grafting patient’s own blood vessel (saphenous vein or internal mammary artery) to connect aorta to coronary artery downstream from site of stenosis as bypass
111
Consideration and indication for revascularization therapy
Revascularization may be considered in patients with ischemic heart disease and any of the following: 1. angina symptoms refractory to medication therapy 2. inadequate cardiovascular quality of life despite medication therapy revascularization indicated in patients with any high-risk features on non-invasive test associated with >3% annual risk of MI or death final decision on revascularization therapy usually by cardiologist and cardiac surgeon taking into account of patient factors, revascularization options and local practices
112
Medication post revascularization
revascularization should address underlying cause of narrowing of blood vessel, so patient do not need to be on beta blocker or ACEI post PCI or CABG
113
Indications for CABG
isolated proximal disease in large coronary arteries (>1.0-1.5mm) is ideal for CABG; small diffusely diseases coronary arteries are not suitable for CABG strong recommendation for CABG > Percutaneous Coronary Intervention (PCI) - 2+ vessel disease in diabetic patients - 3 vessels disease especially if left ventricular ejection fraction (LVEF) <50% - 2 vessel disease with significant proximal left anterior descending (LAD) disease and (LVEF <50% or ischemia on non-invasive testing) - 1 or 2 vessel disease without significant LAD disease who survived sudden cardiac death or sustained ventricular tachycardia (VT) - significant left main coronary artery disease other recommendation for CABG > PCI - unstable or disabling angina unresponsive to medical therapy and PCI - coronary artery rupture, dissection or thrombosis after PCI - post-infarct angina strong recommendation for CABG or PCI - 1 or 2 vessel disease without significant LAD disease but with large area of viable myocardium and high risk criteria on non-invasive testing - recurrent stenosis associated with large area of viable myocardium or high risk criteria on non-invasive testing recommendation for CABG or PCI - 1 vessel disease with significant proximal LAD involvement - repeat CABG for multiple saphenous vein graft stenosis with high risk criteria on non-invasive testing - 1 or 2 vessel disease without significant LAD disease but with moderate area of viable myocardium and high risk criteria on non-invasive testing
114
CABG procedure and different approaches
CABG = using graft (can range from 3-6 grafts) to connect from aorta to coronary arteries distal to sites of occlusion grafts used include saphenous vein grafts (SVG), left internal thoracic / mammary artery (LIMA), right internal thoracic / mammary artery (RIMA), radial artery free graft, right gastroepiploic artery SVG, LIMA and RIMA most commonly used, where IMAs have better long term patency (95% patency for IMA vs. 50% patency for SVG in 10 years) CABG can be done with or without cardiopulmonary bypass (CPB) CPB = pump and oxygenation apparatus that remove blood from inferior & superior vena cava -> performs gas exchange -> return blood into aorta, which allows cardiac arrest for open heart procedure off-pump coronary artery bypass graft surgery (OP-CAB) = surgery performed on beating heart, where stabilization devices hold heart in place and positioning device allow lifting of heart OP-CAB is more technically demanding, but is as safe and well tolerated by most patients compared to CABG on CPB, OP-CAB decreases in-hospital morbidity, blood product transfusion, ICU stay, hospital stay, CK-MB / troponin I levels OP-CAB and CABG on CPB have similar long term outcome OP-CAB used in patients who are poor candidates for CPB such as older / sicker patient, calcified aorta, poor LVEF, severe peripheral vascular disease, severe COPD, chronic renal failure, coagulopathy, transfusion issues, anterior / lateral wall revascularization
115
Absolute and relative contraindications for off-pump CABG
absolute contraindication for OP-CAB: hemodynamic instability, poor quality target vessel, diffusely diseased vessel, calcified coronary vessels relative contraindication for OP-CAB: cardiomegaly, congestive heart failure, critical left main disease, small distal target, recent or current acute myocardial infarction, cardiogenic shock, LVEF <35%
116
Advantage of CABG
CABG can dramatically improve LVEF, which is an important prognostic factor in ischemic heart disease, thereby increasing survival CABG improves survival in >2 vessel disease in diabetic patients, compared to PCI
117
CABG complication
important CABG complications 1. hemorrhage, graft thrombosis 2. myocardial infarction, stroke 3. dysrhythmias 4. sternal dehiscence 5. post-pericardiotomy syndrome (pericarditis), cardiac tamponade redo CABG have higher operative mortality (2-3 times higher than prior operation), usually indicated in symptomatic patients who failed medical therapy and angiography showing progression of disease complication of CPB 1. micro-embolization of gaseous and particulate matter -> stroke and neurocognitive defect 2. immune suppression 3. trauma to formed blood element: thrombocytopenia, platelet dysfunction 4. heparin rebound (increase anti-coagulation from increased heparin level in blood post CPB) 5. systemic inflammatory response syndrome (SIRS) leading to neurological injury, pulmonary dysfunction, heart dysfunction / myocardial infarction, renal dysfunction, coagulopathy 6. failure to wean from CPB
118
Post-Pericardiotomy Syndrome (Pericarditis) pathophysiology
unknown pathophysiology
119
Post-Pericardiotomy Syndrome (Pericarditis) clinical presentation
usually onset weeks to 3 months post-operatively systemic symptoms: fever, malaise cardiac symptoms: pleuritic chest pain physical exam: pericardial friction rub complication: atrial fibrillation, pericardial effusion -> cardiac tamponade, pleural effusion
120
Post-Pericardiotomy Syndrome (Pericarditis) investigation
ECG: PR depression, diffuse ST elevation
121
Post-Pericardiotomy Syndrome (Pericarditis) treatment
medical treatment: 1st line = high dose PO aspirin or NSAID 2nd line = corticosteroids
122
CABG general indication
Strict criteria to be a surgical candidate Requires suitable anatomy (proximal severe occlusion in large vessel)
123
CABG invasiveness
Invasive
124
CABG recovery
Higher short term morbidity Higher rate of complication Longer hospital stay
125
CABG cost
Expensive
126
CABG long term outcomes
Improvement in LVEF Better survival (in >2 vessel disease) Effective long term
127
PCI general indication
More lenient criteria for PCI candidate More lenient criteria for anatomy
128
PCI invasiveness
Less invasive
129
PCI recovery
Less short term morbidity Lower rate of complication Shorter hospital stay
130
PCI cost
Less expensive
131
PCI long term outcomes
Usually does not improve LVEF Worse survival (in >2 vessel disease) Higher rate of re-intervention
132
Myocardial infarction complications
CRASHH PAD = Cardiac Rupture, Arrhythmia, Shock (cardiogenic), Hypertension / Heart Failure, Pericarditis, Aneurysm, DVT/PE myocardial infarction in chronological order post-infarct any time recurrent myocardial infarction any time arrhythmia within first 2 days: tachycardia: sinus tachycardia, atrial fibrillation, ventricular tachycardia, ventricular fibrillation bradycardia: sinus bradycardia, AV block (1st, 2nd, 3rd degree) cardiogenic shock / congestive heart failure within first 2 days myocardial rupture within 1-7 days pericarditis & Dressler’s syndrome (pericarditis weeks post MI) within 1-7 days and 2-8 days thromboembolism 7-10 days, DVT up to 6 months
133
Myocardial infarction surgical complications presentations and the pathophysiology, clinical presentation, diagnosis and management of those presentations
surgical complications usually present with onset 1-7 days post MI and usually present with: 1. Cardiogenic Shock pathophysiology: infarct decreases cardiac output, resulting in cardiogenic shock, which may lead to acute congestive heart failure clinical presentation: cardiogenic shock (hypotension, elevated JVP, multi-organ dysfunction), symptoms and signs of acute congestive heart failure treatment: emergency CABG may improve cardiac function and reduce mortality 2. Free Wall Rupture pathophysiology: rupture (laceration or tearing) of ventricular or atrial walls, which was weakened from infarct clinical presentation: acute cardiac tamponade (Beck’s triad = hypotension, distended JVP, distant & muffled heart sounds) -> immediate death diagnosis: cardiac tamponade on echocardiogram treatment: surgical repair to close rupture with suture or patch after resecting infarcted area 3. Papillary Muscle Rupture pathophysiology: posterior / inferior MI may also involve papillary muscle, where failure to papillary muscle interferes with closure of mitral valve, resulting in acute mitral regurgitation clinical presentation: pan-systolic murmur, acute congestive failure with pulmonary edema diagnosis: papillary muscle dysfunction and mitral regurgitation on echocardiogram treatment: mitral valve replacement via surgery 4. Ventricle Septal Rupture pathophysiology: anterior and inferior infarct of ventricle septum, resulting in perforation clinical presentation: pan-systolic murmur diagnosis: ventricular septal defect on echocardiogram treatment: surgical repair of ventricular septal defect with suture or patch 5. Ventricular Aneurysm pathophysiology: infarct of myocardium result in dyskinetic portion of myocardium, which results in aneurysms causing blood stasis forming clot clinical presentation: acute congestive heart failure, cardiogenic shock diagnosis: visualization of ventricle aneurysm on echocardiogram treatment: ventricular aneurysm with refractory heart failure or ventricular arrhythmia are treated with surgical resection of aneurysm (reconstructive surgery)